Taysha Gene Therapies (TSHA)
(Delayed Data from NSDQ)
$1.53 USD
-0.16 (-9.47%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $1.54 +0.01 (0.65%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.08 |
EPS Last Quarter | -0.09 |
Last EPS Surprise | 10.00% |
ABR | 1.08 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.35 |
Next Year | -0.38 |
EPS (TTM) | 0.03 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.87M | 1.88M | 8.27M | 10.28M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 2.50M | 2.50M | 9.52M | 12.00M |
Low Estimate | 1.12M | 1.13M | 6.78M | 6.85M |
Year ago Sales | 4.75M | 3.60M | 15.45M | 8.27M |
Year over Year Growth Est. | -60.57% | -47.89% | -46.46% | 24.30% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.08 | -0.08 | -0.35 | -0.38 |
# of Estimates | 3 | 3 | 5 | 4 |
Most Recent Consensus | NA | NA | -0.31 | -0.43 |
High Estimate | -0.08 | -0.08 | -0.31 | -0.34 |
Low Estimate | -0.09 | -0.09 | -0.38 | -0.43 |
Year ago EPS | -0.13 | 0.35 | -0.96 | -0.35 |
Year over Year Growth Est. | 38.46% | -122.86% | 63.54% | -9.71% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.08 | -0.08 | -0.35 | -0.38 |
7 Days Ago | -0.08 | -0.08 | -0.35 | -0.38 |
30 Days Ago | -0.08 | -0.08 | -0.35 | -0.38 |
60 Days Ago | -0.08 | -0.08 | -0.35 | -0.38 |
90 Days Ago | -0.09 | -0.09 | -0.41 | -0.39 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.08 | -0.08 | -0.35 | -0.38 |
Zacks Consensus Estimate | -0.08 | -0.08 | -0.35 | -0.38 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.09 | -0.10 | 0.35 | -0.13 | NA |
Estimate | -0.10 | -0.11 | -0.09 | -0.13 | NA |
Difference | 0.01 | 0.01 | 0.44 | 0.00 | 0.12 |
Surprise | 10.00% | 9.09% | 488.89% | 0.00% | 127.00% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more